<DOC>
	<DOCNO>NCT01174459</DOCNO>
	<brief_summary>The survey conduct investigate safety efficacy long-term use BI-Sifrol Tablets Restless Legs Syndrome ( RLS ) patient without renal dysfunction routine medical practice .</brief_summary>
	<brief_title>Survey Long-Term Use BI-SifrolÂ® Tablets Patients With Restless Legs Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<criteria>Inclusion criterion : Patient Restless Legs Syndrome Exclusion criterion :</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>